These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 32571749)

  • 61. Anti-viral effect in chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase.
    Zhao Q; Liu K; Zhu X; Yan L; Ding Y; Xu Y; Lou S; Zhao G; Xie Q; Gao Y; Bao S; Wang H
    Antiviral Res; 2020 Dec; 184():104953. PubMed ID: 33065138
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Peginterferon-α2a combined with response-guided short-term lamivudine improves response rate in hepatitis B e antigen-positive hepatitis B patients: a pilot study.
    Huang Z; Deng H; Zhao Q; Zheng Y; Peng L; Lin C; Zhao Z; Gao Z
    Eur J Gastroenterol Hepatol; 2013 Oct; 25(10):1165-9. PubMed ID: 23571612
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Role of ribavirin in the treatment of chronic hepatitis B].
    Galban García E; Vega Sánchez H; Gra Oramas B; Rodríguez Pérez A; Doval Hernández MA; Haedo Castro D; Rolo F; Lorenzo Morejón I; Ramos Sánchez V
    Gastroenterol Hepatol; 2000 Apr; 23(4):165-9. PubMed ID: 10863856
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A 3-year clinical trial of lamivudine in treatment of patients with chronic hepatitis B.
    Yao GB; Cui ZY; Wang BE; Yao JL; Zeng MD
    Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):188-93. PubMed ID: 15138107
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Factors Associated With Persistent Increase in Level of Alanine Aminotransferase in Patients With Chronic Hepatitis B Receiving Oral Antiviral Therapy.
    Jacobson IM; Washington MK; Buti M; Thompson A; Afdhal N; Flisiak R; Akarca US; Tchernev KG; Flaherty JF; Aguilar Schall R; Myers RP; Subramanian GM; McHutchison JG; Younossi Z; Marcellin P; Patel K
    Clin Gastroenterol Hepatol; 2017 Jul; 15(7):1087-1094.e2. PubMed ID: 28215615
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Efficacy of telbivudine in HBeAg-positive chronic hepatitis B patients with high baseline ALT levels.
    Lv GC; Ma WJ; Ying LJ; Jin X; Zheng L; Yang YD
    World J Gastroenterol; 2010 Aug; 16(32):4095-9. PubMed ID: 20731026
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Predictors of virologic response to Lamivudine treatment in children with chronic hepatitis B infection.
    Hom X; Little NR; Gardner SD; Jonas MM
    Pediatr Infect Dis J; 2004 May; 23(5):441-5. PubMed ID: 15131468
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Factors that predict response of patients with hepatitis B e antigen-positive chronic hepatitis B to peginterferon-alfa.
    Buster EH; Hansen BE; Lau GK; Piratvisuth T; Zeuzem S; Steyerberg EW; Janssen HL
    Gastroenterology; 2009 Dec; 137(6):2002-9. PubMed ID: 19737568
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A noninvasive model to predict liver histology in HBeAg-positive chronic hepatitis B with alanine aminotransferase ≤ 2upper limit of normal.
    Gao S; Li XY; Fan YC; Sun FK; Han LY; Li F; Ji XF; Wang K
    J Gastroenterol Hepatol; 2017 Jan; 32(1):215-220. PubMed ID: 27207016
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A model to predict antiviral treatment in HBeAg negative chronic hepatitis B with alanine aminotransferase≤2 upper limit of normal.
    Gao S; Fan YC; Zhao J; Sun FK; Han J; Zhao ZH; Wang K
    Liver Int; 2014 Aug; 34(7):e229-37. PubMed ID: 24112455
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Efficacy of sequential use of telbivudine in hepatitis B e antigen-positive chronic hepatitis B patients with partial responses to pegylated interferon: a pilot study.
    Huang Z; Zhao Z; Zheng Y; Peng L; Lin C; Deng H; Gao Z
    J Viral Hepat; 2013 Apr; 20 Suppl 1():52-7. PubMed ID: 23458525
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Three year adefovir dipivoxil treatment for hepatitis B e antigen-positive chronic hepatitis B patients].
    Ling N; Zhou Z; Zhang DZ; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2007 May; 15(5):346-9. PubMed ID: 17524266
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A 7-year study of lamivudine therapy for hepatitis B virus e antigen-positive chronic hepatitis B patients in China.
    Yao GB; Zhu M; Cui ZY; Wang BE; Yao JL; Zeng MD
    J Dig Dis; 2009 May; 10(2):131-7. PubMed ID: 19426396
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Hepatitis B virus genotypes and the response to lamivudine therapy].
    Zalewska M; Domagała M; Simon K; Gładysz A
    Pol Arch Med Wewn; 2005 Dec; 114(6):1190-9. PubMed ID: 16789488
    [TBL] [Abstract][Full Text] [Related]  

  • 75. An observational study to evaluate the safety and efficacy of telbivudine in adults with chronic hepatitis B.
    Sulaiman A; Lesmana LA; Nafrialdi ; Helyanna
    Acta Med Indones; 2014 Jan; 46(1):38-43. PubMed ID: 24760807
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pegylated-interferon alpha therapy for treatment-experienced chronic hepatitis B patients.
    Yeh ML; Peng CY; Dai CY; Lai HC; Huang CF; Hsieh MY; Huang JF; Chen SC; Lin ZY; Yu ML; Chuang WL
    PLoS One; 2015; 10(4):e0122259. PubMed ID: 25835020
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Clinical effect of entecavir versus tenofovir in treatment of HBeAg-positive chronic hepatitis B patients with a high viral load: a comparative analysis].
    Shi H; Li XY; Zhu JY; Lin CS; Zhang Y
    Zhonghua Gan Zang Bing Za Zhi; 2017 Oct; 25(10):721-725. PubMed ID: 29108198
    [No Abstract]   [Full Text] [Related]  

  • 78. Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT.
    Kumar M; Sarin SK; Hissar S; Pande C; Sakhuja P; Sharma BC; Chauhan R; Bose S
    Gastroenterology; 2008 May; 134(5):1376-84. PubMed ID: 18471514
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Total serum bile acids predict therapy for HBeAg-negative chronic hepatitis B patients with borderline ALT and high HBV DNA.
    Xie R; Li J; Zhang H; Wang LM; Huang CR; Chen LW
    J Infect Dev Ctries; 2022 Aug; 16(8):1336-1342. PubMed ID: 36099378
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Correlation analysis between ICG-R15 and modified Scheuer score in liver tissues of patients with hepatitis B e antigen-positive/negative chronic hepatitis B].
    Zhang MM; Zhang SW; Hu X; Bao FY; Pei ZY; Liu YY; Ma AD; Zhang LY
    Zhonghua Gan Zang Bing Za Zhi; 2021 Jun; 29(6):565-570. PubMed ID: 34225432
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.